Articles
-
Kemwell Biopharma Brochure
3/29/2012
Kemwell Biopharma will offer services ranging from full-service process development, manufacture, formulation and fill and finish at the cGMP manufacturing facility in Bangalore, India as a one-stop-shop through access to Boehringer Ingelheim's® cell line development with the BI HEX technology platform, followed by a preferred access to the large-scale commercial production of Boehringer Ingelheim at its facilities in Europe.
-
Brochure: RHOBUST® Downstream Processing Technology
2/22/2012
Rhobust® technology is a downstream processing technology for the manufacturing of recombinant proteins and antibodies.
-
Brochure: XD® Technology: Improve Biopharmaceutical Production
2/22/2012
DSM's XD® Technology has been developed to drive yield improvements in the production of biopharmaceuticals.
-
Brochure: Finished Dosage Forms
2/21/2012
DSM is a global provider of finished dosage form manufacturing and related services to pharmaceutical and biopharmaceutical markets.
-
Brochure: Biologics Contract Manufacturing & Technology Solutions
1/30/2012
DSM provides turn-key biologic manufacturing solutions, contract manufacturing for preclinical development, clinical trials or commercial supply and reduced cost, risk, and time to market.
-
Greg Weilersbacher's Expert Advice On Selecting A CMO
11/11/2011
Life Science Leader magazine put together an executive roundtable article on the CMO selection process for a 2011 special supplement. The intent — to gain a better understanding of the some of the challenges faced during the partnering and provide insights on how to overcome. By Rob Wright
-
Clinical Trial Material Production And Testing: What Your CMO Is Not Telling You
6/7/2011
Manufacturing clinical trial material (CTM), and the costs for the associated fill/finish and release work, most likely are not the costliest portions of the pharmaceutical process chain. By Alexander Mello, Director, Project Management
-
White Paper: Clinical Trial Material Production And Testing: What Your CMO Is Not Telling You
6/7/2011
Manufacturing clinical trial material (CTM), and the costs for the associated fill/finish and release work, most likely are not the costliest portions of the pharmaceutical process chain. By Alexander Mello, Director, Project Management
This website uses cookies to ensure you get the best experience on our website. Learn more